MUC16
MUC16, also known as CA-125 (cancer agent 125 or carcinoma antigen 125), is a cell surface protein that is actively expressed in corneal and conjunctival epithelia. It is a heavily N-glycosylated large membrane-associated mucin protein with over 22000 amino acids and structurally, it is divided into a Ser/Thr-rich N-terminal domain, a C-terminal transmembrane contain domain, and a highly repetitive middle domain that is comprised of more than 60 partially conserved tandem repeats. The hydrophilicity of MUC16 created by its glycans enables MUC16 to provide a lubricating barrier against infectious agents and particles while its cytoplasmic tail has also been indicated to bind members of the ERM protein family and interact with cytoskeleton.
The overexpression of MUC16 has been associated with several carcinomas, especially ovarian carcinomas and ovarian low malignant potential (LMP) tumors. MUC16 has served as a biomarker for ovarian carcinoma for a long time and it is believed to facilitate cancer development by mechanisms including immune system evasion, metastatic invasion, induced motility, and chemotherapy resistance. Thus, it is an important therapeutic target for ovarian cancer.
Entrez Gene ID: 94025
UniProt ID: Q8WXI7

Catalog | Product name | Similar to | Antibody | Linker | Payload | Data sheet | Inquiry |
ADC-W-020 | Anti-MUC16 (clone 3A5)-Mc-VC-PABC-MMAE ADC | Chimeric Anti-MUC16 antibody, clone # std ch 3A5 | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
![]() |
Inquiry | |
ADC-W-022 | Anti-MUC16 (clone 3A5)-VC-MMAE ADC | Anti-MUC16-antibody, clone # std ch 3A5 | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
![]() |
Inquiry | |
ADC-W-154 | Anti-MUC16 (clone 3A5)-BMPEO-DM1 ADC | Anti-MUC16 antibody, clone # 3A5 | BMPEO (bis-maleimido-trioxyethylene glycol) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
![]() |
Inquiry | |
ADC-W-238 | Anti-MUC16 (clone ch11D10)-Mc-MMAF ADC | Chimeric Anti-MUC16 lgG1 Antibody, clone # ch11D10 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
![]() |
Inquiry | |
ADC-W-239 | Anti-MUC16 (clone ch11D10)-VC-MMAF ADC | Chimeric Anti-MUC16 lgG1 Antibody, clone # ch11D10 | VC (valine-citrulline) | MMAF (Monomethyl auristatin F) |
![]() |
Inquiry | |
ADC-W-427 | Anti-MUC16 (Sofituzumab)-VC-MMAE ADC | Humanized Anti-MUC16 Antibody, Sofituzumab | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
![]() |
Inquiry | |
ADC-W-466 | Anti-MUC16-Mc-VC-PABC-MMAE ADC | Chimeric Anti-MUC16 Antibody | MC-VC-PABC (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE (Monomethyl auristatin E) |
![]() |
Inquiry | |
ADC-W-564 ![]() |
Anti-MUC16-VC-MMAE ADC | RG-7458 | Anti-MUC16 Antibody | VC (valine-citrulline) | MMAE (Monomethyl auristatin E) |
![]() |
Inquiry |
ADC-W-1634 | Anti-MUC16 (Abagovomab)-SMCC-DM1 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1635 | Anti-MUC16 (Abagovomab)-SPDB-DM4 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1636 | Anti-MUC16 (Abagovomab)-MC-MMAF ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | MC (maleimidocaproyl) | MMAF |
![]() |
Inquiry | |
ADC-W-1637 | Anti-MUC16 (Abagovomab)-MC-Vc-PAB-MMAE ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
![]() |
Inquiry | |
ADC-W-1638 | Anti-MUC16 (Abagovomab)-MC-Vc-PAB-SN38 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
![]() |
Inquiry | |
ADC-W-1639 | Anti-MUC16 (Abagovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Abagovomab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
![]() |
Inquiry | |
ADC-W-1640 | Anti-MUC16 (Igovomab)-SMCC-DM1 ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1641 | Anti-MUC16 (Igovomab)-SPDB-DM4 ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1642 | Anti-MUC16 (Igovomab)-MC-MMAF ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | MC (maleimidocaproyl) | MMAF |
![]() |
Inquiry | |
ADC-W-1643 | Anti-MUC16 (Igovomab)-MC-Vc-PAB-MMAE ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
![]() |
Inquiry | |
ADC-W-1644 | Anti-MUC16 (Igovomab)-MC-Vc-PAB-SN38 ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
![]() |
Inquiry | |
ADC-W-1645 | Anti-MUC16 (Igovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Murine Anti-MUC16 Fab2 fragment, Igovomab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
![]() |
Inquiry | |
ADC-W-1646 | Anti-MUC16 (Oregovomab)-SMCC-DM1 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1647 | Anti-MUC16 (Oregovomab)-SPDB-DM4 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
![]() |
Inquiry | |
ADC-W-1648 | Anti-MUC16 (Oregovomab)-MC-MMAF ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | MC (maleimidocaproyl) | MMAF |
![]() |
Inquiry | |
ADC-W-1649 | Anti-MUC16 (Oregovomab)-MC-Vc-PAB-MMAE ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
![]() |
Inquiry | |
ADC-W-1650 | Anti-MUC16 (Oregovomab)-MC-Vc-PAB-SN38 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
![]() |
Inquiry | |
ADC-W-1651 | Anti-MUC16 (Oregovomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Oregovomab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
![]() |
Inquiry | |
ADC-W-2565 | Anti-MUC16 (Sofituzumab)-SMCC-DM1 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | SMCC (N-succinimidyl 4-(Nmaleimidomethyl)cyclohexane-1-carboxylate) | DM1 (N2'-Deacetyl-N2'-(3-mercapto-1-oxopropyl)maytansine) |
![]() |
Inquiry | |
ADC-W-2566 | Anti-MUC16 (Sofituzumab)-SPDB-DM4 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
![]() |
Inquiry | |
ADC-W-2567 | Anti-MUC16 (Sofituzumab)-MC-MMAF ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | MC (maleimidocaproyl) | MMAF |
![]() |
Inquiry | |
ADC-W-2568 | Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-MMAE ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
![]() |
Inquiry | |
ADC-W-2569 | Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-SN38 ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
![]() |
Inquiry | |
ADC-W-2570 | Anti-MUC16 (Sofituzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | Humanized Anti-MUC16 IgG1-kappa antibody, Sofituzumab | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
![]() |
Inquiry |
If you can’t find your product on this list? Please directly send email to info@creative-biolabs.com
For Research Use Only. NOT FOR CLINICAL USE.
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.